Risk that closing conditions, including regulatory approvals required under competition laws and other applicable laws in Japan and overseas, will not be satisfied in connection with the divestment of the science business, affecting completion of the divestment or its scheduled completion date. This risk was reduced when the procedures were completed in April 2023.